Previous Close | 15.33 |
Open | 15.30 |
Bid | 6.10 x 800 |
Ask | 0.00 x 800 |
Day's Range | 15.02 - 15.39 |
52 Week Range | 13.05 - 23.25 |
Volume | |
Avg. Volume | 1,611,229 |
Market Cap | 1.77B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | 13.92 |
EPS (TTM) | 1.10 |
Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Oct 07, 2008 |
1y Target Est | 22.13 |
Subscribe to Yahoo Finance Plus to view Fair Value for MDRX
CHICAGO, June 29, 2022--Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and apparatus for risk adjustment patent ("Dynamic Intervention Planning") has been issued by the United States Patent and Trademark Office (USPTO).
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Olink Holding AB publ Sponsored ADR (OLK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.